symbol,statement_type,period_end,line_item,value
NEPHROCARE.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.246495
NEPHROCARE.NS,income,2025-03-31 00:00:00,Normalized EBITDA,73995000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Total Unusual Items,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,24601000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,130609000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,EBITDA,73995000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,EBIT,49394000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Interest Income,-1101000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Interest Expense,1101000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Interest Income,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Normalized Income,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Total Expenses,426186000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Basic Average Shares,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Diluted EPS,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Basic EPS,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Income,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,36389000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Tax Provision,11904000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Pretax Income,48293000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,15269000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Special Income Charges,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Write Off,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-1101000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,1101000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Operating Income,34125000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Operating Expense,295577000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Other Operating Expenses,195062000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,24601000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,24601000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Selling General And Administration,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
NEPHROCARE.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
NEPHROCARE.NS,income,2025-03-31 00:00:00,Gross Profit,329702000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Cost Of Revenue,130609000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Total Revenue,460311000.0
NEPHROCARE.NS,income,2025-03-31 00:00:00,Operating Revenue,460311000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.276537
NEPHROCARE.NS,income,2024-03-31 00:00:00,Normalized EBITDA,68361000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Total Unusual Items,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,5276000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,90846000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,EBITDA,68361000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,EBIT,63085000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Interest Income,-851000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Interest Expense,851000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Interest Income,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Normalized Income,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Total Expenses,212923000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Diluted Average Shares,16486400.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Basic Average Shares,16486400.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Diluted EPS,2.730978
NEPHROCARE.NS,income,2024-03-31 00:00:00,Basic EPS,2.730978
NEPHROCARE.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Income,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,45024000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Tax Provision,17210000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Pretax Income,62234000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,3700000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Special Income Charges,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Write Off,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-851000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,851000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Operating Income,59385000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Operating Expense,122077000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Other Operating Expenses,95225000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,5276000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,5276000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Selling General And Administration,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,
NEPHROCARE.NS,income,2024-03-31 00:00:00,General And Administrative Expense,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,
NEPHROCARE.NS,income,2024-03-31 00:00:00,Gross Profit,181462000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Cost Of Revenue,90846000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Total Revenue,272308000.0
NEPHROCARE.NS,income,2024-03-31 00:00:00,Operating Revenue,272308000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-83360.185902
NEPHROCARE.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.283538
NEPHROCARE.NS,income,2023-03-31 00:00:00,Normalized EBITDA,36194000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Total Unusual Items,-294000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-294000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,7880000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,48824000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,EBITDA,35900000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,EBIT,28020000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Interest Income,-1469000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Interest Expense,909000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Interest Income,17000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Normalized Income,19634639.814098
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Total Expenses,142060000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,8680000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Diluted Average Shares,
NEPHROCARE.NS,income,2023-03-31 00:00:00,Basic Average Shares,
NEPHROCARE.NS,income,2023-03-31 00:00:00,Diluted EPS,
NEPHROCARE.NS,income,2023-03-31 00:00:00,Basic EPS,
NEPHROCARE.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Income,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,19424000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Tax Provision,7687000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Pretax Income,27111000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,7000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Special Income Charges,-294000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Write Off,294000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-1469000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,577000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,909000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,17000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Operating Income,28867000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Operating Expense,93236000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Other Operating Expenses,47242000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,7880000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,7880000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Selling General And Administration,18122000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,716000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,General And Administrative Expense,17406000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,8680000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Gross Profit,122103000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Cost Of Revenue,48824000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Total Revenue,170927000.0
NEPHROCARE.NS,income,2023-03-31 00:00:00,Operating Revenue,170927000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.3
NEPHROCARE.NS,income,2022-03-31 00:00:00,Normalized EBITDA,1264000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Total Unusual Items,0.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,1114000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,14830000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,EBITDA,1264000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,EBIT,150000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Interest Income,-143000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Interest Expense,148000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Interest Income,23000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Normalized Income,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Total Expenses,34102000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,3805000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Diluted Average Shares,16486400.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Basic Average Shares,16486400.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Diluted EPS,-0.005944
NEPHROCARE.NS,income,2022-03-31 00:00:00,Basic EPS,-0.005944
NEPHROCARE.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Income,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,-98000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Tax Provision,100000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Pretax Income,2000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,3000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Special Income Charges,0.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Write Off,0.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-143000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,18000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,148000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,23000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Operating Income,142000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Operating Expense,19272000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Other Operating Expenses,10260000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,1114000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,1114000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Selling General And Administration,1002000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,67000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,General And Administrative Expense,935000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,3805000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Gross Profit,19414000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Cost Of Revenue,14830000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Total Revenue,34244000.0
NEPHROCARE.NS,income,2022-03-31 00:00:00,Operating Revenue,34244000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Total Unusual Items,0.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
NEPHROCARE.NS,income,2021-03-31 00:00:00,EBITDA,
NEPHROCARE.NS,income,2021-03-31 00:00:00,EBIT,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Interest Income,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Interest Expense,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Interest Income,78000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Normalized Income,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Total Expenses,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,1008000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Diluted Average Shares,16486400.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Basic Average Shares,16486400.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Diluted EPS,0.053802
NEPHROCARE.NS,income,2021-03-31 00:00:00,Basic EPS,0.053802
NEPHROCARE.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Income,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Tax Provision,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Pretax Income,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Special Income Charges,0.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Write Off,0.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,11000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,78000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Operating Income,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Operating Expense,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Selling General And Administration,225000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,0.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,General And Administrative Expense,225000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,1008000.0
NEPHROCARE.NS,income,2021-03-31 00:00:00,Gross Profit,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Total Revenue,
NEPHROCARE.NS,income,2021-03-31 00:00:00,Operating Revenue,
